Similar effects have been observed in liver tissue, kidney tissue, and brain tissue
In summary, recent CV outcomes trials with GLP-1RAs have shown promising benefits in CV care of T2D patients, and GLP-1RAs have been accordingly listed as a second line therapy in T2D patients with established atherosclerotic CV disease, alongside SGLT2 inhibitors [5, 6]
Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses
1 2 3 "Bali Mynah Fact Sheet, Lincoln Park Zoo" "Bali launches starling breeding program"
(PubMed) Wiederholt T, Heise R, Skazik C, et al